Martini Jeffrey S 4/A
4/A · PALVELLA THERAPEUTICS, INC. · Filed Feb 10, 2025
Insider Transaction Report
Form 4/AAmended
Martini Jeffrey S
Chief Scientific Officer
Transactions
- Award
Incentive Stock Option (right to buy)
2025-02-05+5,373→ 5,373 totalExercise: $14.76Exp: 2035-02-05→ Common Stock (5,373 underlying) - Award
Non-Qualified Stock Option (right to buy)
2025-02-05+123,559→ 123,559 totalExercise: $14.76Exp: 2035-02-05→ Common Stock (123,559 underlying)
Footnotes (1)
- [F1]The stock options will vest in equal monthly tranches over 48 months